Related Experiment Videos

["In vitro" susceptibility of group A beta-haemolytic streptococcus]

S Noviello1, F Ianniello, S Esposito

  • 1Clinica Malattie Infettive Seconda Università degli Studi di Napoli.

Insights

Streptococcus pyogenes caused over 30% of pediatric acute pharyngo tonsillitis cases. While no resistance to beta-lactams was found, high erythromycin resistance in Streptococcus pyogenes necessitates ongoing surveillance.

Area of Science:

  • Pediatric Infectious Diseases
  • Bacteriology
  • Epidemiology

Context:

  • Acute pharyngo tonsillitis is a common pediatric illness.
  • Streptococcal infections are a significant concern in children.
  • Understanding bacterial etiology and resistance patterns is crucial for effective treatment.

Purpose:

  • To determine the incidence of streptococcal etiology in pediatric acute pharyngo tonsillitis.
  • To assess the in vitro susceptibility of Group A beta-hemolytic Streptococcus (S. pyogenes) isolates.
  • To inform public health strategies regarding antibiotic resistance.

Summary:

  • An epidemiological survey of 827 pediatric patients from March 1995 to November 1996 identified Streptococcus pyogenes as the cause in 32.7% of acute pharyngo tonsillitis cases.
  • In vitro testing revealed no resistance to beta-lactam antibiotics among the S. pyogenes isolates.
  • A high rate of resistance (38.7%) to erythromycin was observed in the bacterial isolates.

Impact:

  • Highlights the prevalence of S. pyogenes in pediatric pharyngo tonsillitis.
  • Identifies a significant emerging resistance to erythromycin, impacting treatment options.
  • Underscores the need for continuous epidemiological surveillance of S. pyogenes antibiotic resistance in the community.

Related Concept Videos